Rituximab Maintenance After Autologous Transplantation
Status:
Terminated
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research is to see if Rituxan (rituximab) therapy given after high
dose chemotherapy and transplant of a patients own stem cells will prevent or delay the
return of the lymphoma.